Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul McCrone

Showing results (1-10 of 339) with videos related to

Pageof 34
Sort By:
Mental Health Today (Brighton, England)|April 7, 2012
Does early intervention for psychosis services make economic sense?Paul McCrone
The British Journal of Psychiatry. Supplement|November 21, 2007
Health economic measures in schizophrenia researchPaul McCrone
Journal of Pain and Symptom Management|July 21, 2009
Capturing the costs of end-of-life care: comparisons of multiple sclerosis, Parkinson's disease, and dementiaPaul McCrone
The British Journal of Psychiatry : the Journal of Mental Science|May 3, 2013
IAPT is probably not cost-effectivePaul McCrone
BMJ (Clinical Research Ed.)|January 26, 2023
Britain can afford the NHS: health is a "handicraft industry"Paul McCrone
Child and Adolescent Mental Health|December 10, 2024
Debate: Where to next for universal school-based mental health interventions? Universal versus targeted school-based mental health interventions: a health economic perspectivePaul McCrone
Journal of Mental Health (Abingdon, England)|February 1, 2019
'Money doesn't talk, it swears'Paul McCrone
Applied Health Economics and Health Policy|March 16, 2013
The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluationsEvanthia Achilla, Paul McCrone
The British Journal of Psychiatry : the Journal of Mental Science|November 3, 2016
Invited commentary … On poverty, politics and psychologyGlenys Parry, Paul McCrone
Pharmacoeconomics|May 24, 2017
The Cost of Relapse in SchizophreniaMark Pennington, Paul McCrone
Pageof 34

Showing results (1-10 of 339) with videos related to

Sort By:
Pageof 34
Mental Health Today (Brighton, England)|April 7, 2012
Does early intervention for psychosis services make economic sense?Paul McCrone
The British Journal of Psychiatry. Supplement|November 21, 2007
Health economic measures in schizophrenia researchPaul McCrone
Journal of Pain and Symptom Management|July 21, 2009
Capturing the costs of end-of-life care: comparisons of multiple sclerosis, Parkinson's disease, and dementiaPaul McCrone
The British Journal of Psychiatry : the Journal of Mental Science|May 3, 2013
IAPT is probably not cost-effectivePaul McCrone
BMJ (Clinical Research Ed.)|January 26, 2023
Britain can afford the NHS: health is a "handicraft industry"Paul McCrone
Child and Adolescent Mental Health|December 10, 2024
Debate: Where to next for universal school-based mental health interventions? Universal versus targeted school-based mental health interventions: a health economic perspectivePaul McCrone
Journal of Mental Health (Abingdon, England)|February 1, 2019
'Money doesn't talk, it swears'Paul McCrone
Applied Health Economics and Health Policy|March 16, 2013
The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluationsEvanthia Achilla, Paul McCrone
The British Journal of Psychiatry : the Journal of Mental Science|November 3, 2016
Invited commentary … On poverty, politics and psychologyGlenys Parry, Paul McCrone
Pharmacoeconomics|May 24, 2017
The Cost of Relapse in SchizophreniaMark Pennington, Paul McCrone
Pageof 34